Vitality Biopharma Advisor Will Present Pediatric IBD Case Study

Cannabis Investing News

Vitality Biopharma announced company advisor Dr. Natasha Ryz will be presenting at an international research symposium in Montréal.

Vitality Biopharma (OTCQB:VBIO) announced company advisor Dr. Natasha Ryz will be presenting at an international research symposium in Montréal.
As quoted in the press release:

Dr. Ryz will provide a poster presentation titled “Cannabinoid Treatment Induces Remission in Drug-Resistant Pediatric Inflammatory Bowel Disease: A Case Report.” The case report provides clinical results describing a 13-year old boy with drug-resistant Crohn’s disease that achieved disease remission after cannabinoid treatment. Dr. Ryz holds a Ph.D. in Experimental Medicine from the University of British Columbia, where she was a Vanier Scholar.

Click here to read the full press release.

Source: www.marketwired.com

The Conversation (0)
×